MRK vs SYK
By Alex · Tickerpine
Merck & Co., Inc. vs Stryker Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | SYK |
|---|---|---|
| Price | $148.69 | $275.31 |
| Market cap | $366.84B | $105.60B |
| P/E ratio | 119.0 | 28.2 |
| ROE | 6.96% | 16.51% |
| Profit margin | 4.77% | 14.43% |
| Revenue growth | 5.10% | 9.40% |
| Dividend yield | 2.29% | 1.28% |
| Beta | 0.23 | 0.77 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs SYK in plain English
- MRK is the bigger company — about 3.5× the market cap of SYK.
- SYK is cheaper on earnings (P/E 28.2 vs 119.0).
- SYK earns a higher return on equity (17% vs 7%).
- SYK is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.29% vs 1.28%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
SYK return calculator
See what $1,000 in Stryker Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.